New test detects cancer risk in type 2 diabetes patients

Individuals with type 2 diabetes who are at higher risk of certain cancers could be identified by a simple blood test, this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) (Madrid, 9-13 September) will hear.

Pα+ Psychedelic Bulletin #174: Psilocybin Outperforms Escitalopram After 6 Months… or Does It? Survey Results Reveal Healthcare Practitioner Attitudes to Psychedelics; and more… – Psychedelic Alpha

In this Issue Six-Month Follow-Up Data Shows Psilocybin Outperforms Escitalopram… or Does It? Survey Reveals Healthcare Practitioner Attitudes to Psychedelics MIND Foundation Plots 700-Patient Psilocybin

September 27, 2024

FDA expands label for Novartis and Roche’s blockbuster, converts EMD Serono’s NSCLC drug to full approval

The FDA on Friday signed off on an expanded label for Novartis and Roche’s blockbuster Xolair (omalizumab) and on Thursday converted the accelerated to full

February 17, 2024

MedPAC Report on Medicare Advantage Growth, High Costs Generates Kerfuffle

A Medicare Payment Advisory Commission (MedPAC) meeting turned unusually contentious Friday as one member, Brian Miller, MD, MPH, of Johns Hopkins University in Baltimore, accused

January 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.